Literature DB >> 2058808

Does the presence of a measurable blood alcohol level in a potential organ donor affect the outcome of liver transplantation?

T I Hassanein1, J S Gavaler, D Fishkin, R Gordon, T E Starzl, D H Van Thiel.   

Abstract

The widespread application of hepatic transplantation has created a tremendous demand for donor organs. An assessment of donor parameters is thought to be important in selecting good donors; however, the criteria utilized have not been standardized. This study was performed to determine the effect of a measurable donor blood alcohol level on graft survival. Fifty-two patients who underwent orthotopic liver transplantation at the University of Pittsburgh were included in the study. Twenty-five patients received liver grafts from donors having a blood alcohol level between 0.04 and 0.4 g/l with a mean of 0.17 g/l. Twenty-seven patients received a liver graft from a donor who had no measurable blood alcohol. There were no differences between these two groups of donors regarding the time of initial hospitalization until the time of donation. Graft failure within the first 30 days was 24% for those receiving an organ from an alcohol-positive donor as compared with 22.2% in those receiving an organ from an alcohol negative donor. The recipient mortality rate was 16% and 11%, respectively. No relationships between the donor blood alcohol level and organ performance, frequency of primary graft nonfunction, or number of episodes of acute cellular rejection were evident. Based upon these data, the presence of a measurable blood alcohol level in a donor should not mitigate against organ donation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2058808      PMCID: PMC3032355          DOI: 10.1111/j.1530-0277.1991.tb01873.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  10 in total

1.  Selection criteria for liver transplantation donors.

Authors:  N L Ascher
Journal:  Transplant Proc       Date:  1989-06       Impact factor: 1.066

2.  Analysis of donor and recipient variables and early graft function after orthotopic liver transplantation.

Authors:  R Mimeault; D Grant; C Ghent; J Duff; W Wall
Journal:  Transplant Proc       Date:  1989-04       Impact factor: 1.066

3.  Should patients with end-stage alcoholic liver disease have a new liver?

Authors:  S Schenker; H S Perkins; M F Sorrell
Journal:  Hepatology       Date:  1990-02       Impact factor: 17.425

4.  Relevance of donor liver selection and graft viability in a liver transplantation program.

Authors:  N P Mora; V S Turrión; F Pardo; F Pereira; J Herrera; J Ardaiz; P Olivares; J Murcia; J Vázquez; J A Cienfuegos
Journal:  Transplant Proc       Date:  1988-10       Impact factor: 1.066

Review 5.  Liver transplantation (1).

Authors:  T E Starzl; A J Demetris; D Van Thiel
Journal:  N Engl J Med       Date:  1989-10-12       Impact factor: 91.245

Review 6.  Liver transplantation: an overview.

Authors:  W C Maddrey; D H Van Thiel
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

7.  The role of hepatocyte enlargement in hepatic pressure in cirrhotic and noncirrhotic alcoholic liver disease.

Authors:  L M Blendis; H Orrego; I R Crossley; J E Blake; A Medline; Y Isreal
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

Review 8.  Liver allograft rejection: an overview of morphologic findings.

Authors:  A J Demetris; S G Qian; H Sun; J J Fung
Journal:  Am J Surg Pathol       Date:  1990       Impact factor: 6.394

9.  Analysis of donor criteria for the prediction of outcome in clinical liver transplantation.

Authors:  L Makowka; R D Gordon; S Todo; N Ohkohchi; J W Marsh; A G Tzakis; H Yokoi; J Ligush; C O Esquivel; M Satake
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

10.  Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury.

Authors:  S Kakizoe; K Yanaga; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1990-06       Impact factor: 17.425

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.